» Articles » PMID: 23301560

Amino Acid Grafted Chitosan for High Performance Gene Delivery: Comparison of Amino Acid Hydrophobicity on Vector and Polyplex Characteristics

Overview
Date 2013 Jan 11
PMID 23301560
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

To develop a safe, effective, and biocompatible gene delivery vector, a series of hydrophobic amino acid grafted chitosan (AGC) derivatives were synthesized by carbodiimide mediated coupling reaction. Chemical characterization of AGC polymers was performed by NMR and elemental analysis. AGC polymers demonstrated excellent blood compatibility and cell viability, as evaluated by hemolysis and MTT assay, respectively. AGC polymers could effectively bind and condense plasmid DNA (pDNA) to form polyplexes in the size range of 161-263 nm and possessed net cationic charge. The resultant polyplex showed 3.4-5.4-fold greater cellular uptake and 13-30-fold higher transfection efficiency in HEK 293 cells as compared to unmodified chitosan. Moreover, both cellular uptake and transfection efficiency improved with the increasing amino acid hydrophobicity. Hydrophobic amino acid substitution contributed to the enhance pDNA release at cytosolic pH. These data demonstrate AGC polymers as a promising novel nonviral gene delivery vector.

Citing Articles

Intranasal administration of angiotensin receptor shRNA to brain lowers blood pressure in spontaneously hypertensive rats.

Lamptey R, Sun C, Singh J Biomed Pharmacother. 2024; 182:117790.

PMID: 39721326 PMC: 11874126. DOI: 10.1016/j.biopha.2024.117790.


Penetratin and Mannose-Functionalized Cannabidiol Lipid Nanoparticles Encapsulating the BDNF Gene Reduce Amyloid-Induced Inflammation.

Chaulagain B, Singh J Mol Pharm. 2024; 22(1):154-167.

PMID: 39588752 PMC: 11874068. DOI: 10.1021/acs.molpharmaceut.4c00811.


A Recent Review on Cancer Nanomedicine.

Mani Giri P, Banerjee A, Layek B Cancers (Basel). 2023; 15(8).

PMID: 37190185 PMC: 10136552. DOI: 10.3390/cancers15082256.


Neurogenic Hypertension, the Blood-Brain Barrier, and the Potential Role of Targeted Nanotherapeutics.

Lamptey R, Sun C, Layek B, Singh J Int J Mol Sci. 2023; 24(3).

PMID: 36768536 PMC: 9916775. DOI: 10.3390/ijms24032213.


A novel method for genetic transformation of using modified-hydroxyapatite nanoparticles as a plasmid DNA vehicle.

Deshmukh K, Ramanan S, Kowshik M Nanoscale Adv. 2022; 1(8):3015-3022.

PMID: 36133607 PMC: 9418897. DOI: 10.1039/c8na00365c.